From articles published since 2023.
Review articles
- Do we need Moodle in medical education? A review of its impact and utility
-
Seri Jeong, Hyunyong Hwang
-
Kosin Med J. 2023;38(3):159-168. Published online September 22, 2023
-
DOI: https://doi.org/10.7180/kmj.23.139
-
-
7,251
View
-
169
Download
-
6
Citations
-
Abstract
PDF
PubReader
ePub
- Various learning management systems (LMSs) are available to facilitate the development, management, and distribution of digital resources for both face-to-face and online instruction. In recent decades, these methods have shown potential for greater efficiency compared to traditional "chalk and talk" approaches. Additionally, they have paved the way for the establishment of ubiquitous learning environments, marking a new era in education. In a trend accelerated by the coronavirus disease 2019 pandemic, LMSs have been increasingly adopted to overcome the restrictions inherent to in-person education. In medical education, LMSs such as Moodle, Canvas, Blackboard Learn, and others have been introduced and used to support teaching, learning, and assessment activities. Of these, Moodle stands out as the most popular choice for many medical schools and institutions, primarily due to its flexibility, functionality, and user-friendliness. The learning environment is gradually transforming from traditional in-person teaching to a hybrid educational approach, driven by the need to fulfill diverse educational demands. Numerous research studies have examined the usability of Moodle in medical education, demonstrating its effectiveness in addressing challenges related to adaptive personalized learning, collaborative learning, blended learning, and more. Consequently, Moodle has emerged as a valuable solution for medical educators seeking a versatile and robust platform to enhance their teaching methodologies. The present review focuses on the practical utilization of Moodle in medical education and the advantages it offers to this field.
-
Citations
Citations to this article as recorded by

- Technology-Enabled Institutional Readiness for Agile-Blended Learning: A Framework for Educational Innovation
Jessie Ming Sin Wong, Kam Cheong Li
SN Computer Science.2025;[Epub] CrossRef - Development of an LMS-based e-literacy management model for managing the junior high school literacy movement
Oliva Ike Kurniawati
Primary: Jurnal Pendidikan Guru Sekolah Dasar.2025; 14(1): 71. CrossRef - Exploring the Opportunities and Challenges of Healthcare Innovation in UK Higher Education: A Narrative Review
Renske Emicke, Ashley Shepherd, Dylan Powell
Nursing Reports.2025; 15(5): 171. CrossRef - Exploring structural equations modelling on the use of modified UTAUT model for evaluating online learning
Stephen Gbenga Fashoto, Yinusa Akintoye Faremi, Elliot Mbunge, Olumide Owolabi
Educational Technology Quarterly.2024; 2024(3): 319. CrossRef - Looking Back on Digital Medical Education Over the Last 25 Years and Looking to the Future: Narrative Review
Oluwadamilola Ogundiya, Thahmina Jasmine Rahman, Ioan Valnarov-Boulter, Tim Michael Young
Journal of Medical Internet Research.2024; 26: e60312. CrossRef - The effectiveness of Moodle's “Lesson” feature in pre-learning about arterial puncture and blood transfusion procedures
Haeyoung Lee, Sang-Shin Lee, Hyunyong Hwang
Kosin Medical Journal.2023; 38(4): 278. CrossRef
- Revolutionizing gut health: exploring the role of gut microbiota and the potential of microbiome-based therapies in lower gastrointestinal diseases
-
Yong Eun Park, Jae Hyun Kim
-
Kosin Med J. 2023;38(2):98-106. Published online June 23, 2023
-
DOI: https://doi.org/10.7180/kmj.23.115
-
-
3,594
View
-
71
Download
-
2
Citations
-
Abstract
PDF
PubReader
ePub
- The gut microbiota comprises a collection of microorganisms residing in the human digestive system, including bacteria, viruses, and fungi. These microbes have critical roles in food breakdown, immune system regulation, and the production of essential nutrients. Several lower gastrointestinal (GI) diseases, including inflammatory bowel disease, irritable bowel syndrome, and colorectal cancer, have been associated with dysbiosis, which refers to an imbalance in the gut microbiota. Additionally, the gut microbiome and its microbial compounds affect disease development and the host’s immune response. Alterations in the gut-brain axis microbiome are also implicated in lower GI diseases. Therefore, microbiome-based therapies that regulate the gut microbiota (e.g., fecal microbiota transplantation and probiotics) are essential for the prevention and treatment of these diseases. This review aims to highlight the significance of gut microbiota and microbiome-based therapies in managing lower GI diseases.
-
Citations
Citations to this article as recorded by

- Advances in research on the intestinal microbiota in the mechanism and prevention of colorectal cancer (Review)
Weitong Sun, Shize Ma, Dongdong Meng, Chaoxing Wang, Jinbo Zhang
Molecular Medicine Reports.2025; 31(5): 1. CrossRef - From Food Supplements to Functional Foods: Emerging Perspectives on Post-Exercise Recovery Nutrition
Lifeng Wang, Qing Meng, Chun-Hsien Su
Nutrients.2024; 16(23): 4081. CrossRef
Original article
- Revascularization of immature retinas with retinopathy of prematurity using combination therapy of deferred laser treatment after a single intravitreal bevacizumab injection
-
Ju Seouk Lee, Ki Yup Nam, Ji Eun Lee, Joo Eun Lee, Sang Joon Lee
-
Kosin Med J. 2023;38(1):28-35. Published online March 28, 2023
-
DOI: https://doi.org/10.7180/kmj.22.145
-
-
2,542
View
-
34
Download
-
2
Citations
-
Abstract
PDF
PubReader
ePub
- Background
This study aimed to observe the extent of retinal vascularization in patients with retinopathy of prematurity (ROP) who underwent deferred laser treatment (LT) after a single intravitreal bevacizumab injection (IVB).
Methods
This study retrospectively evaluated 40 consecutive eyes in 21 infants who received a single IVB or LT. Deferred LT was performed in cases of ROP recurrence after a single IVB. To assess the amount of retinal vascularization between the initial IVB and deferred LT, the cases were divided into three groups based on treatment: single IVB, deferred LT after a single IVB, and prompt LT. The growth and associated complications were compared between groups.
Results
There were 12, 16, and 12 eyes in the single IVB, deferred LT, and prompt LT groups, respectively. Deferred LT was performed at an average of 7.9 weeks after a single IVB. In the single IVB group, retinal vascularization proceeded to zone III, whereas the prompt LT group did not show any growth of vascularization beyond the laser scars. In the deferred LT group, during the window period before LT, retinal vascularization progressed from zone I to zone II posterior and from zone II posterior to zone II anterior, respectively, without further ROP recurrence.
Conclusions
Retinal vascularization progressed during the deferred window period, thereby reducing the area of the retina ablated by LT. A single IVB followed by deferred LT can be an alternative treatment option to prevent ablation of zone I or multiple IVBs.
-
Citations
Citations to this article as recorded by

- Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis
Amparo Ortiz-Seller, Pablo Martorell, Honorio Barranco, Isabel Pascual-Camps, Esteban Morcillo, José L. Ortiz
Survey of Ophthalmology.2024;[Epub] CrossRef - What is the effect of deferred laser treatment on reactivated retinopathy of prematurity after anti-VEGF injection?
Ji Hye Jang
Kosin Medical Journal.2023; 38(1): 1. CrossRef
Review article
- Faculty development: the need to ensure educational excellence and health care quality
-
Hyekyung Shin, Min-Jeong Kim
-
Kosin Med J. 2023;38(1):4-11. Published online March 27, 2023
-
DOI: https://doi.org/10.7180/kmj.23.109
-
-
5,787
View
-
186
Download
-
2
Citations
-
Abstract
PDF
PubReader
ePub
- The definition of faculty development has been refined and expanded over the past few decades, and various definitions have been used in higher education. Initially, faculty development was defined as activities that help teachers improve teaching skills, design better curricula, and improve the organizational environment for education. Since then, as the focus of faculty development has shifted from individual professors to institutional needs, faculty development is now defined as the personal and professional development of professors, clinicians, researchers, and managers to meet institutional goals, visions, and missions in social terms and moral responsibility to the community. Faculty development in medical education is universally needed to recognize and cope with widespread changes in education, including the traditional role of professors, advances in pedagogical theory, changes in learning styles, innovative curriculum models, and evaluation philosophy. However, critics have pointed out that most universities could not actively implement faculty development or accept professors’ various demands. In this paper, various reports related to faculty development are reviewed to summarize how faculty development has progressed and present future directions for accepting various opinions to improve educational excellence and the quality of health care.
-
Citations
Citations to this article as recorded by

- Needs and gaps of faculty development for medical schools
Ji Hyun Im, Wha Sun Kang, Seung Hee Lee, Dae Chul Jeong, Dae Hyun Kim, Man-Sup Lim, Miran Kim, Ji-Hyun Seo, Dong Hyeon Lee
Korean Journal of Medical Education.2024; 36(2): 189. CrossRef - Current status and challenges of faculty development in Korean medical education and strategies for advancement
Dong Hyeon Lee
Korean Journal of Medical Education.2024; 36(4): 415. CrossRef
Original article
- Did the COVID-19 pandemic impact the surgical treatment of febrile acute appendicitis at a single center in Korea, a country not under lockdown? Observational cohort study
-
Youngil Choi, Youngsik Kim
-
Kosin Med J. 2025;40(1):55-65. Published online March 27, 2025
-
DOI: https://doi.org/10.7180/kmj.24.125
-
-
430
View
-
4
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Background
This study analyzed the impact of the coronavirus disease 2019 (COVID-19) pandemic on acute appendicitis (AA) treatment in Korea, a country that did not implement lockdown measures.
Methods
A retrospective analysis was conducted during two discretionary time periods: a pre COVID-19 period, and a COVID-19 period. This study included adult and pediatric patients diagnosed with AA who underwent surgical treatment. Clinical and laboratory parameters, changes in surgery timing, disease severity, and postoperative outcomes were compared between the pre and post pandemic periods.
Results
The study included a total of 221 patients, with 139 receiving appendectomy in the COVID-19 cohort and 82 in the control cohort. In patients without fever, operative time was significantly longer during the COVID-19 period (p<0.01). Among patients presenting with fever, the rate of complicated AA was higher during the COVID-19 period than in the control period (p<0.01). During the COVID-19 period, the diagnostic and preoperative delay times, as well as postoperative hospital stays, were longer (p<0.05), and the incidence of postoperative complications and other hospital diagnoses was higher (p<0.01) during the COVID-19 period than in the control period. Multivariate analysis showed that age (p=0.03) and the presence of fever (p<0.01) were independent risk factors for complicated AA.
Conclusions
Older patients and those with fever were at greater risk of severe AA. During outbreaks of infectious diseases like COVID-19, careful consideration is needed regarding surgical interventions in older patients with fever. Understanding vulnerabilities is crucial for disease management in the future.
-
Citations
Citations to this article as recorded by

- Acute appendicitis surgery in the COVID-19 era: delays without deterioration of outcomes
Sang-Yong Son
Kosin Medical Journal.2025; 40(1): 1. CrossRef
Review article
- The ethics of using artificial intelligence in medical research
-
Shinae Yu, Sang-Shin Lee, Hyunyong Hwang
-
Kosin Med J. 2024;39(4):229-237. Published online December 6, 2024
-
DOI: https://doi.org/10.7180/kmj.24.140
-
-
22,203
View
-
251
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- The integration of artificial intelligence (AI) technologies into medical research introduces significant ethical challenges that necessitate the strengthening of ethical frameworks. This review highlights the issues of privacy, bias, accountability, informed consent, and regulatory compliance as central concerns. AI systems, particularly in medical research, may compromise patient data privacy, perpetuate biases if they are trained on nondiverse datasets, and obscure accountability owing to their “black box” nature. Furthermore, the complexity of the role of AI may affect patients’ informed consent, as they may not fully grasp the extent of AI involvement in their care. Compliance with regulations such as the Health Insurance Portability and Accountability Act and General Data Protection Regulation is essential, as they address liability in cases of AI errors. This review advocates a balanced approach to AI autonomy in clinical decisions, the rigorous validation of AI systems, ongoing monitoring, and robust data governance. Engaging diverse stakeholders is crucial for aligning AI development with ethical norms and addressing practical clinical needs. Ultimately, the proactive management of AI’s ethical implications is vital to ensure that its integration into healthcare improves patient outcomes without compromising ethical integrity.
-
Citations
Citations to this article as recorded by

- Integrating Artificial Intelligence in Orthopedic Care: Advancements in Bone Care and Future Directions
Rahul Kumar, Kyle Sporn, Joshua Ong, Ethan Waisberg, Phani Paladugu, Swapna Vaja, Tamer Hage, Tejas C. Sekhar, Amar S. Vadhera, Alex Ngo, Nasif Zaman, Alireza Tavakkoli, Mouayad Masalkhi
Bioengineering.2025; 12(5): 513. CrossRef
Original article
- Stereopsis and clinical features of esotropia patients accompanied by congenital mild ptosis
-
Heeyoung Choi, Su-Jin Kim, Seung Ahn Yang, Kwang Eon Han
-
Kosin Med J. 2024;39(4):259-264. Published online December 3, 2024
-
DOI: https://doi.org/10.7180/kmj.24.123
-
-
835
View
-
15
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Background
To evaluate binocular function and clinical features in patients with esotropia (ET) accompanied by congenital ptosis.
Methods
Clinical records of 44 ET patients with congenital ptosis (ET-ptosis group) and 71 age-matched ET patients without ptosis (ET only group) who presented for eye examination between January 2016 and December 2021 were retrospectively reviewed. Best-corrected visual acuity (BCVA), magnitude of esodeviation and stereopsis at the first visit were reviewed. Stereopsis and other clinical features of the two groups were compared.
Results
The mean (±standard deviation) age of overall patients was 5.7 (±1.9) years. The margin reflex distance 1 (MRD1) of patients with ptosis was greater than 0 but less than or equal to 2, indicating that mild ptosis was included. There was no significant difference in the distribution of age, sex, spherical equivalent refractive errors, BCVA, or magnitude of ET (at distance or near) between the two groups (all p>0.05). Furthermore, stereopsis and the number of patients with amblyopia did not differ significantly between the two groups. The magnitudes of esodeviation, near stereopsis and BCVA did not differ significantly between the 0Conclusions
In patients with ET and congenital mild ptosis, stereopsis and visual acuity were not different from those in ET only patients. The presence of coexisting mild ptosis might not have a further deleterious impact on binocular function in ET patients.
-
Citations
Citations to this article as recorded by

- Congenital mild ptosis might not influence visual function in esotropia patients
Chang Zoo Kim
Kosin Medical Journal.2024; 39(4): 227. CrossRef
Review articles
- Oncoplastic breast-conserving surgery: evolution, techniques, and the emerging role of acellular dermal matrix
-
Jun Ho Choi, Yoonsoo Kim
-
Kosin Med J. 2024;39(3):153-159. Published online September 26, 2024
-
DOI: https://doi.org/10.7180/kmj.24.129
-
-
1,500
View
-
41
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Oncoplastic breast-conserving surgery (OBCS) has revolutionized breast cancer treatment, aiming to achieve optimal oncological outcomes while preserving an aesthetically favorable appearance. This review explores the evolution, techniques, and outcomes of OBCS, with a particular focus on the emerging role of acellular dermal matrix in volume replacement techniques. We conducted a comprehensive literature review using PubMed, Medline, and Cochrane databases, focusing on studies published between 2010 and 2024. OBCS demonstrates comparable oncological safety to traditional breast-conserving surgery, with local recurrence rates ranging from 2.7% to 5.7% at 5 years. Patient satisfaction rates are consistently high, with 85% to 95% reporting good to excellent aesthetic outcomes. Volume replacement techniques using acellular dermal matrix show promising results, with one study reporting that 94% of patients were highly satisfied with cosmetic outcomes. Although the current results are encouraging, future advancements in OBCS may require innovative approaches, including the integration of robotic surgery and artificial intelligence technologies.
-
Citations
Citations to this article as recorded by

- Trends and Perspectives in Oncoplastic Breast Surgery: Findings From a Web-Based Survey With the Korean Breast Cancer Society
Jeeyeon Lee, Byeongju Kang, Ho Yong Park, Sang Yull Kang, Min Kyoon Kim, Hong-Kyu Kim, Sun Young Min, Min-Ki Seong, Tae-Kyung Robyn Yoo, Seokwon Lee, Eun-Shin Lee, Kyung-Hwak Yoon, Eun-Kyu Kim
Journal of Breast Cancer.2025;[Epub] CrossRef
- Current understanding of modulated electro-hyperthermia in cancer treatment
-
Sungmin Kim, Jesang Yu, Jihun Kang, Yunkyung Kim, Taek Yong Ko
-
Kosin Med J. 2024;39(3):160-168. Published online September 23, 2024
-
DOI: https://doi.org/10.7180/kmj.24.127
-
-
2,444
View
-
45
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Traditional hyperthermia involves increasing the temperature at the tumor site to above 39 ℃, inducing death in cancer cells. Although hyperthermia is an effective cancer treatment, its clinical application has decreased due to potential complications, including damage to surrounding normal tissue. In recent years, modulated electro-hyperthermia (mEHT) has emerged as an effective and safe treatment modality. mEHT selectively heats tumor cells to 42–43 °C, while reducing the average temperature in the treatment area, including the surrounding normal tissue, compared to conventional methods. Additionally, mEHT may be used in combination with systemic chemotherapy and radiation therapy in tumor treatment, providing a synergistic effect to increase efficacy. As chemotherapy and radiation therapy technologies advance, the application of combined mEHT may improve clinical outcomes. In this study, we review and discuss reports on the clinical outcomes of mEHT combined with chemotherapy and/or radiation therapy, which are established anticancer treatments.
-
Citations
Citations to this article as recorded by

- Advances and applications of hyperthermia in tumor therapy: Mechanisms, techniques, and clinical integration
Cuihua Gu, Jinzhong Zhang, Wenhua Gao, Jisong Wang, Kun Mou, Xuequn Zhang, Jiude Qi
International Communications in Heat and Mass Transfer.2025; 164: 108895. CrossRef
Original article
- Capsule endoscopy in Kazakhstan: a multicenter clinical experience
-
Sang Jun Sohn, Kanat Batyrbekov, Ainura Galiakbarova, Laura Yerdaliyeva, Jamilya Kaibullayeva, Jeongwoo Ju, Haejin Lee, Yeoun Joo Lee
-
Kosin Med J. 2024;39(3):179-185. Published online July 26, 2024
-
DOI: https://doi.org/10.7180/kmj.24.116
-
-
1,621
View
-
39
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Background
By analyzing small bowel capsule endoscopy (SBCE) performed in two large hospitals in Kazakhstan, we aimed to explore the characteristics of patients representative of Central Asia and the technical characteristics of SBCE.
Methods
SBCE cases were retrospectively analyzed. A descriptive analysis was conducted on the patients’ demographic data, diagnosis, and clinical symptoms. The results of SBCE, such as the lesions found, transit time and retention rate in the stomach and small bowel, and bowel visualization quality, were analyzed. Complications related to SBCE were investigated.
Results
SBCE was performed in 123 patients. Abdominal pain (81.3%) and chronic diarrhea (66.7%) were the most common symptoms, followed by weight loss (25.2%) and gastrointestinal bleeding (15.4%). The most common disease was Crohn’s disease (52.0%). Definite lesions, such as ulcers, polyps, and bleeding, were identified in 55.3% of patients. SBCE was successfully completed in all cases except for 11 (9.1%). The average small bowel transit time was 4 hours and 28 minutes. Excellent visualization (>75% of mucosa) was reported in 82.5% of patients. No patients experienced complications.
Conclusions
SBCE performed in Kazakhstan showed a high diagnostic yield with high-quality patient selection and no complications.
-
Citations
Citations to this article as recorded by

- Exploring the impact of capsule endoscopy in Kazakhstan: a significant milestone
Jong Yoon Lee
Kosin Medical Journal.2024; 39(3): 151. CrossRef
Review article
Original article
- Clinical features of coronavirus disease 2019 in Korean pediatric patients: a single-center retrospective study
-
Ji Eun Jeong, Hai Lee Chung, Young Hwan Kim, Nawon Lee, Younghyun Kim, Yoon Young Jang
-
Kosin Med J. 2024;39(2):99-111. Published online June 10, 2024
-
DOI: https://doi.org/10.7180/kmj.24.106
-
-
1,920
View
-
29
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Background
To address the public’s fear of coronavirus disease 2019 (COVID-19), understanding the clinical features of the disease is essential. However, research on the clinical features of COVID-19, including illness duration and post-acute COVID-19, in Korean pediatric patients has been limited. Therefore, this study investigated the clinical features of COVID-19 based on the medical records of pediatric patients with a history of COVID-19 who visited a single center.
Methods
In total, 311 patients were included in this study. The presence and duration of 19 symptoms were examined. Additionally, clinical features were investigated by dividing the patients into different age ranges. Patients aged 6 and above were further categorized according to the presence of asthma, while adolescent patients were divided into vaccinated and unvaccinated groups.
Results
Fever and cough were the most common symptoms. The mean illness duration was 2–4 days. Only 3.5% of the patients were asymptomatic. Post-acute COVID-19 was observed in 13.2% of the patients. The incidence of most symptoms tended to increase with age. Post-acute COVID-19 was observed more frequently in patients with asthma than in those without asthma. Vaccinated patients experienced less fever, vomiting, and fatigue than unvaccinated patients.
Conclusions
Our data suggest that most patients had mild disease lasting less than a week, and the clinical course may differ depending on the presence of asthma. The findings also indicate that vaccination may alleviate the symptoms of COVID-19 in breakthrough infections.
-
Citations
Citations to this article as recorded by

- Coronavirus disease 2019 infection in pediatric patients in Korea: insights and implications
Yu Jin Jung
Kosin Medical Journal.2024; 39(2): 81. CrossRef
Case report
- Remimazolam in pediatric surgery under general anesthesia: a case series
-
Hong-Sik Shon, Seyeon Park, Jung-Pil Yoon, Yeong Min Yoo, Jimin Lee, Da Eun Lee, Hee Young Kim
-
Kosin Med J. 2024;39(3):201-206. Published online May 9, 2024
-
DOI: https://doi.org/10.7180/kmj.24.105
-
-
1,948
View
-
49
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Remimazolam is a promising drug for general anesthesia due to its rapid onset, short duration, and short context-sensitive half-life. However, its use in pediatric patients remains off-label, and limited prospective data have been published. Herein, we report successful anesthesia using remimazolam in pediatric patients who had a history of epilepsy or required shared airway surgery. In all cases, remimazolam provided general anesthesia, and flumazenil was used for reversal with rapid recovery. Remimazolam offers advantages for pediatric anesthesia in scenarios with a risk of seizure or shared airway surgery. However, the potential for higher bispectral index values and the risk of anaphylaxis in dextran-allergic patients necessitate caution and further research.
-
Citations
Citations to this article as recorded by

- Remimazolam: Is the new “wonder drug” in anesthesia any good in children?
Tom G. Hansen, Thomas Engelhardt
Acta Anaesthesiologica Scandinavica.2025;[Epub] CrossRef
Review article
- Gastric cancer and metabolic syndrome
-
Hyeong Ho Jo
-
Kosin Med J. 2024;39(1):26-34. Published online March 22, 2024
-
DOI: https://doi.org/10.7180/kmj.24.108
-
-
2,467
View
-
38
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Gastric cancer (GC), a prevalent disease in Asian countries, presents a substantial global health challenge. The risk factors for GC include Helicobacter pylori infection, diet, smoking, alcohol, and metabolic syndrome (MetS). This review meticulously examines the intricate connections between MetS and GC, focusing on visceral adipocytes, hormonal factors, obesity, and their impact on survival outcomes. Visceral adipocytes, which secrete inflammatory cytokines and hormones, play a pivotal role in influencing cancer development. Hormonal factors demonstrate nuanced associations with specific GC subtypes, underscoring the complexity of their impact. Large-scale studies exploring obesity-related factors reveal sex-specific nuances and underscore the importance of considering overall weight and body composition. Furthermore, the review explores the impact of eradication therapy for H. pylori infection, which is the most significant factor in the onset of GC, on the components of MetS. Additionally, the influence of MetS on postoperative outcomes and survival in GC patients highlights the interplay between therapeutic interventions and lifestyle factors. This comprehensive exploration sheds light on the multifaceted relationship between MetS and GC, providing valuable insights for future research and preventive strategies.
-
Citations
Citations to this article as recorded by

- Chemotherapy for Metastatic Gastric Cancer
Sung Eun Kim, Moo In Park, Myung Hun Lee
The Korean Journal of Gastroenterology.2025; 85(1): 1. CrossRef
Original article
- Clinical efficacy and safety of autologous serum intramuscular injection in patients with mild-to-moderate atopic dermatitis: a prospective, open-label, uncontrolled study
-
Gil-Soon Choi, Jong Bin Park, Young-Ho Kim, Hee-Kyoo Kim
-
Kosin Med J. 2024;39(1):51-59. Published online March 19, 2024
-
DOI: https://doi.org/10.7180/kmj.24.101
-
-
3,438
View
-
40
Download
-
1
Citations
-
Abstract
PDF
PubReader
ePub
- Background
Autologous blood therapy (ABT) has been used to treat atopic dermatitis (AD) for over a century, even though evidence supporting its efficacy is lacking. We aimed to investigate the effectiveness and safety of autologous serum intramuscular injection (ASIM), which is a modified form of ABT, in treating mild-to-moderate AD.
Methods
This study was a 12-week, open-label, prospective, uncontrolled trial. Following a 4-week run-in period, 22 out of 25 screened patients received ASIM once a week for 4 weeks in conjunction with standard treatment. The primary outcome measure was the Eczema Area and Severity Index (EASI), while the secondary outcomes included the Scoring Atopic Dermatitis (SCORAD) score, Dermatologic Life Quality Index (DLQI), and patient ratings of pruritus, sleep difficulty, disease status, and treatment effectiveness. Safety parameters were also assessed.
Results
EASI scores showed a non-statistically significant trend toward improvement during ASIM intervention. Patients with at least a 50% improvement in the EASI score at 4 weeks were older and had lower peripheral eosinophil counts (p<0.05). Secondary endpoints, including the SCORAD score, pruritus, sleep difficulty, and DLQI, demonstrated statistically significant improvements at week 4 compared to baseline (p<0.05). No significant adverse reactions were observed.
Conclusions
This pioneering study suggests that repeated ASIM may improve the clinical symptoms of mild-to-moderate AD, particularly in terms of pruritus and overall quality of life. However, further research with a larger sample size is required to establish the clinical significance of these findings.
-
Citations
Citations to this article as recorded by

- What are the clinical usefulness and scientific value of intramuscular injection of autologous serum (autologous serum therapy) in patients with atopic dermatitis?
Dong-Ho Nahm
Kosin Medical Journal.2024; 39(1): 1. CrossRef